Author: PR Newswire
-
RISE FESTIVAL UNVEILS OFFICIAL SCHEDULE FOR 10TH ANNIVERSARY CELEBRATION IN THE MOJAVE DESERT
Full performance schedule details and last chance to purchase tickets October 3–5, 2025 | Mojave Desert, Las Vegas www.RISEfestival.com Link to Assets LAS VEGAS, Sept. 12, 2025 /PRNewswire/ — RISE Festival today revealed the full performance schedule for its landmark 10th anniversary, returning October 3, 4, and 5, to the Mojave Desert just 20 miles…
-
DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
PHILADELPHIA, Sept. 12, 2025 /PRNewswire/ — National plaintiffs’ law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) (“Spectrum” or the “Company”) on behalf of investors who purchased or otherwise acquired common shares of Spectrum between March 17, 2022 through September 22, 2022 (the “Class Period”). Investor Deadline: Investors…
-
Berger Montague Reminds RxSight, Inc. (NASDAQ: RXST) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by September 22, 2025
PHILADELPHIA, Sept. 12, 2025 /PRNewswire/ — Berger Montague PC is investigating potential securities fraud claims on behalf of investors in RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery. Its RxSight system involves the…
-
Shawn “JAY-Z” Carter Comments: “With Caesars Palace Times Square, we’re investing in this community, creating real opportunities, and building on the legacy of the world’s crossroads. Our plan delivers generational economic growth.”
Public Hearing Process Shows Majority Support for Caesars Palace Times Square Local residents, small business owners, labor unions, Broadway workers, community leaders speak out in favor of project that will bring enormous investment in jobs and $250 million in public benefits *** Photos and Video HERE *** NEW YORK, Sept. 12, 2025 /PRNewswire/ — The…
-
CTO Investors Have Opportunity to Lead CTO Realty Growth, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 11, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”), of the important October 7, 2025 lead plaintiff deadline. So What: If…
-
BHVN Deadline: BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit
NEW YORK, Sept. 11, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 12, 2025 lead plaintiff deadline. So What: If you purchased Biohaven securities…
-
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
NEW YORK, Sept. 11, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the “Class Period”), of the important October 6, 2025 lead plaintiff deadline. So What: If you purchased Altimmune securities…
-
Amazfit Announces Olympic Medalist Grant Fisher as New Brand Ambassador
Elite distance runner joins Amazfit’s growing athlete team and will play an active role in product testing and innovation MILPITAS, Calif., Sept. 11, 2025 /PRNewswire/ — Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced two-time Olympic medalist and American record holder Grant Fisher as the newest addition to…
-
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NEW YORK, Sept. 11, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”), of the important September 30, 2025 lead plaintiff deadline. So What: If you purchased…